AU731048B2 - Biological material free of viral and molecular pathogens and a process for the production thereof - Google Patents

Biological material free of viral and molecular pathogens and a process for the production thereof Download PDF

Info

Publication number
AU731048B2
AU731048B2 AU25612/97A AU2561297A AU731048B2 AU 731048 B2 AU731048 B2 AU 731048B2 AU 25612/97 A AU25612/97 A AU 25612/97A AU 2561297 A AU2561297 A AU 2561297A AU 731048 B2 AU731048 B2 AU 731048B2
Authority
AU
Australia
Prior art keywords
biological material
ligand
pathogen
receptor
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU25612/97A
Other languages
English (en)
Other versions
AU2561297A (en
Inventor
Noel Barrett
Friedrich Dorner
Johann Eibl
Thomas Hammerle
Gerhard Polsler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oesterreichisches Institut fuer Haemoderivate
Original Assignee
Immuno AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno AG filed Critical Immuno AG
Publication of AU2561297A publication Critical patent/AU2561297A/en
Application granted granted Critical
Publication of AU731048B2 publication Critical patent/AU731048B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU25612/97A 1996-04-30 1997-04-23 Biological material free of viral and molecular pathogens and a process for the production thereof Ceased AU731048B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT780/96 1996-04-30
AT0078096A AT403477B (de) 1996-04-30 1996-04-30 Biologisches material frei von viralen und molekularen pathogenen und verfahren zur herstellung
PCT/AT1997/000075 WO1997040861A1 (de) 1996-04-30 1997-04-23 Biologisches material frei von viralen und molekularen pathogenen und verfahren zur herstellung

Publications (2)

Publication Number Publication Date
AU2561297A AU2561297A (en) 1997-11-19
AU731048B2 true AU731048B2 (en) 2001-03-22

Family

ID=3499569

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25612/97A Ceased AU731048B2 (en) 1996-04-30 1997-04-23 Biological material free of viral and molecular pathogens and a process for the production thereof

Country Status (8)

Country Link
EP (1) EP0900089A1 (de)
JP (1) JP2000510107A (de)
AT (1) AT403477B (de)
AU (1) AU731048B2 (de)
CA (1) CA2253300A1 (de)
IL (1) IL126810A0 (de)
NO (1) NO984979L (de)
WO (1) WO1997040861A1 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6617119B2 (en) 1997-02-21 2003-09-09 The Regents Of The University Of California Assay for specific strains of multiple disease related conformations of a protein
US6916419B2 (en) 1997-02-21 2005-07-12 The Regents Of The University Of California Device for removal of prions from blood, plasma and other liquids

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720355B2 (en) 1997-02-21 2004-04-13 The Regents Of The University Of California Sodium dodecyl sulfate compositions for inactivating prions
US6620629B1 (en) 1997-02-21 2003-09-16 The Regents Of The University Of California Method for detecting prions
AU726999B2 (en) * 1997-06-13 2000-11-30 Baxter Aktiengesellschaft Process for reducing the concentration of viral and molecular pathogens in a biological material
DE19752898A1 (de) * 1997-11-28 1999-08-05 Centeon Pharma Gmbh Verfahren zum Nachweis hoher Vierenkonzentrationen im Blutplasma und/oder Blutserum mittels der Polymerasekettenreaktion
US5977324A (en) * 1998-02-20 1999-11-02 The Regents Of The University Of California Process for concentrating protein with disease-related conformation
ATE318176T1 (de) * 1998-08-31 2006-03-15 Julian L Ambrus Verfahren zur entfernung von hiv und anderen viren aus blut
CA2392797A1 (en) * 1999-12-02 2001-06-07 V.I. Technologies, Inc. Method of identifying a ligand for a target molecule
AU2002242086A1 (en) * 2001-02-02 2002-08-19 Chemocentryx, Inc. Chemomagnetic retrieval of cmv and cmv infected cells
CN101124315A (zh) 2003-01-17 2008-02-13 伊势龙医学股份有限公司 利用凝集素亲和性血液透析去除血液中病毒的方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2263781A1 (de) * 1972-07-13 1975-10-10 Research Corp
EP0110407A2 (de) * 1982-12-02 1984-06-13 Armour Pharmaceutical Corporation Biologische Produkte frei von Hepatitis-B und nicht-A-nicht-B-Hepatitis
WO1990015992A1 (en) * 1989-06-15 1990-12-27 Smith William I Jr Method and apparatus for inactivating infectious agents in and resisting coagulation of biological fluids

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63243032A (ja) * 1987-03-27 1988-10-07 Green Cross Corp:The トロンビンの加熱処理方法
EP0443724B1 (de) * 1990-02-20 1999-03-17 Baxter International Inc. Gereinigtes, virusfreies menschliches Thrombin
EP0447984A1 (de) * 1990-03-20 1991-09-25 Abbott Laboratories Hyperimmunglobulin gegen Hepatitis-C-Virus und Verfahren zur Herstellung
DE4125625C2 (de) * 1991-08-02 1999-12-02 Octapharma Ag Glarus Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen
DE4142908C2 (de) * 1991-12-24 1994-02-10 Octapharma Ag Glarus Verfahren zur Herstellung eines virusinaktivierten Prothrombinkomplex-Konzentrats (PPSB)
EP0679405A1 (de) * 1994-04-25 1995-11-02 Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk Verfahren zur Abtrennung von Viren aus Proteinlösungen
AT406019B (de) * 1995-05-08 2000-01-25 Immuno Ag Verfahren zur herstellung eines arzneimittels enthaltend ein oder mehrere plasmaderivate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2263781A1 (de) * 1972-07-13 1975-10-10 Research Corp
EP0110407A2 (de) * 1982-12-02 1984-06-13 Armour Pharmaceutical Corporation Biologische Produkte frei von Hepatitis-B und nicht-A-nicht-B-Hepatitis
WO1990015992A1 (en) * 1989-06-15 1990-12-27 Smith William I Jr Method and apparatus for inactivating infectious agents in and resisting coagulation of biological fluids

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6617119B2 (en) 1997-02-21 2003-09-09 The Regents Of The University Of California Assay for specific strains of multiple disease related conformations of a protein
US6916419B2 (en) 1997-02-21 2005-07-12 The Regents Of The University Of California Device for removal of prions from blood, plasma and other liquids

Also Published As

Publication number Publication date
EP0900089A1 (de) 1999-03-10
WO1997040861A1 (de) 1997-11-06
IL126810A0 (en) 1999-08-17
CA2253300A1 (en) 1997-11-06
NO984979L (no) 1998-12-23
NO984979D0 (no) 1998-10-26
AT403477B (de) 1998-02-25
JP2000510107A (ja) 2000-08-08
AU2561297A (en) 1997-11-19
ATA78096A (de) 1997-07-15

Similar Documents

Publication Publication Date Title
Burnouf et al. Nanofiltration of plasma‐derived biopharmaceutical products
ES2295308T3 (es) Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
Parkkinen et al. A modified caprylic acid method for manufacturing immunoglobulin G from human plasma with high yield and efficient virus clearance
AU731048B2 (en) Biological material free of viral and molecular pathogens and a process for the production thereof
RU2008916C1 (ru) Способ пастеризации водного раствора иммуноглобулина
Troccoli et al. Removal of viruses from human intravenous immune globulin by 35 nm nanofiltration
JP2008500959A (ja) ウイルスについて安全な免疫グロブリンの製造方法
Bos et al. Virus validation of pH 4-treated human immunoglobulin produced by the Cohn fractionation process
Yokoyama et al. Removal of small non‐enveloped viruses by nanofiltration
Yap The viral safety of intravenous immune globulin
CA1066191A (en) Hepatitis b vaccine
US6391657B1 (en) Removal of viruses from protein solutions by ultrafiltration
Burnouf et al. Place of nanofiltration for assuring viral safety of biologicals
CA2063303C (en) Preparation of virus-free immunoglobulins
Borovec et al. Inactivation kinetics of model and relevant blood-borne viruses by treatment with sodium hydroxide and heat
Van Holten et al. Incorporation of an additional viral‐clearance step into a human immunoglobulin manufacturing process
Rollag et al. Viral safety of blood derivatives by immune neutralization
Caballero et al. Viral safety characteristics of Flebogamma® DIF, a new pasteurized, solvent-detergent treated and Planova 20 nm nanofiltered intravenous immunoglobulin
US5419906A (en) Preparation of human immunoglobulin free of hepatitis C
JP3735137B2 (ja) 生物学的活性なタンパク質の溶液における殺ウイルス剤としてのアゾールの使用
Gao et al. Enhancement in the safety of immune globulins prepared from high-risk plasma
SK174799A3 (en) Process for reducing the concentration of viral and molecular pathogens in a biological material
US5159064A (en) Preparation of virus-free antibodies
Burnouf et al. Strategy of virus removal/inactivation of plasma-derived products: Interest of nanofiltration as a new virus elimination method
Terpstra Viral safety of blood and plasma products

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired